Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions

Objectives:To evaluate the effectiveness of adalimumab in patients with psoriatic arthritis (PsA) and identify predictors of good clinical response for joint and skin lesions.Methods:Patients received adalimumab 40 mg every other week in addition to standard therapy in this prospective, 12-week, ope...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of the rheumatic diseases 2010-02, Vol.69 (2), p.394-399
Hauptverfasser:	Van den Bosch, F, Manger, B, Goupille, P, McHugh, N, Rødevand, E, Holck, P, van Vollenhoven, R F, Leirisalo-Repo, M, FitzGerald, O, Kron, M, Frank, M, Kary, S, Kupper, H
Format:	Artikel
Sprache:	eng
Schlagworte:	Adalimumab Adult Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized Antirheumatic Agents - therapeutic use Arthritis Arthritis, Psoriatic - drug therapy Biological and medical sciences Clinical and epidemiological research Confidence intervals Dermatologic Agents - therapeutic use Dermatology Diseases of the osteoarticular system Female Humans Immunomodulators Laboratories Life Sciences Male Medical sciences Medicin och hälsovetenskap Middle Aged Miscellaneous. Osteoarticular involvement in other diseases Nail Diseases - drug therapy Pain Patients Pharmacology. Drug treatments Prognosis Prospective Studies Psoriasis Psoriasis - drug therapy Psoriasis. Parapsoriasis. Lichen Rheumatism Rheumatology Severity of Illness Index Studies TNF inhibitors Treatment Outcome Tumor necrosis factor-TNF
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!